| 臺大學術典藏 |
2022-01-11T06:49:50Z |
Excimer light photototherapy of segmental and non-segmental vitiligo: Experience in Taiwan
|
Cheng Y.-P.; HSIEN-YI CHIU; Jee S.-H.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:50Z |
Multiple discrete, punched-out ulcers in a patient with pemphigus vulgaris
|
HSIEN-YI CHIU; Chang C.-Y.; Hsueh P.-R.; Tsai T.-F.; Liu I.L.; Wang L.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:50Z |
HLA polymorphism among Chinese patients with chronic plaque psoriasis: Subgroup analysis
|
HSIEN-YI CHIU; Huang P.-Y.; Jee S.-H.; Hu C.-Y.; Chou C.-T.; Chang Y.-T.; Hwang C.-Y.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:49Z |
Localized AL amyloidosis in a patient with diffuse large B-cell lymphoma of the breast
|
HSIEN-YI CHIU; Chu C.-Y.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:49Z |
A crusted plaque on the right nipple
|
HSIEN-YI CHIU; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:49Z |
Transformation of myxofibrosarcoma into myxoinflammatory fibroblastic sarcoma
|
HSIEN-YI CHIU; Chen J.-S.; Hsiao C.-H.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:48Z |
The effectiveness and safety of adalimumab in the treatment of non-reimbursed patients with mild-to-moderate psoriasis
|
HSIEN-YI CHIU; Wang T.-S.; Chang C.-Y.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:47Z |
Erlotinib-induced generalized eczema craquel? and follicular rash sparing the previous radiation field
|
HSIEN-YI CHIU; Cheng Y.P.; Jee S.H.; Tsai T.F. |
| 臺大學術典藏 |
2022-01-11T06:49:47Z |
T helper type 17 in psoriasis: From basic immunology to clinical practice
|
HSIEN-YI CHIU; Cheng Y.-P.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:46Z |
Pityriasis rubra pilaris with polyarthritis treated with adalimumab
|
HSIEN-YI CHIU; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:46Z |
The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C
|
HSIEN-YI CHIU; Chen C.-H.; Wu M.-S.; Cheng Y.-P.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:45Z |
A case of latent tuberculosis reactivation in a patient treated with ustekinumab without concomitant isoniazid chemoprophylaxis in the PEARL trial
|
Tsai T.-F.; HSIEN-YI CHIU; Song M.; Chan D. |
| 臺大學術典藏 |
2022-01-11T06:49:45Z |
Etanercept use for psoriasis in Taiwan: A case series study
|
HSIEN-YI CHIU; Wang T.-S.; Cho Y.-T.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:43Z |
Human leucocyte antigen-Cw6 as a predictor for clinical response to ustekinumab, an interleukin-12/23 blocker, in Chinese patients with psoriasis: A retrospective analysis
|
HSIEN-YI CHIU; Wang T.-S.; Chan C.-C.; Cheng Y.-P.; Lin S.-J.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:43Z |
Correlation of thiopurine methyltransferase and inosine triphosphate pyrophosphatase polymorphisms and adverse effects induced by azathioprine treatment in Taiwanese dermatology patients
|
Wang T.-S.; HSIEN-YI CHIU; Wu L.S.-H.; Chu C.-Y.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:42Z |
Development of lichen striatus in a psoriasis patient treated with adalimumab
|
Lin I.-C.; Wang T.-S.; HSIEN-YI CHIU; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:42Z |
Practical experience of ustekinumab in patients with moderate-to-severe psoriasis who had inadequate therapeutic response to previous tumor necrosis factor blockers
|
Wang T.-C.; HSIEN-YI CHIU; Wang T.-S.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:42Z |
Risk factor analysis for the immunogenicity of adalimumab associated with decreased clinical response in Chinese patients with psoriasis
|
HSIEN-YI CHIU; Wang T.-S.; Chan C.-C.; Lin S.-J.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:41Z |
Increased risk of chronic kidney disease in rheumatoid arthritis associated with cardiovascular complications - A national population-based cohort study
|
HSIEN-YI CHIU; Huang H.-L.; Li C.-H.; Chen H.-A.; Yeh C.-L.; Chiu S.-H.; Lin W.-C.; Cheng Y.-P.; Tsai T.-F.; Ho S.-Y. |
| 臺大學術典藏 |
2022-01-11T06:49:41Z |
Increased risk of arrhythmia in patients with psoriatic disease: A nationwide population-based matched cohort study
|
HSIEN-YI CHIU; Chang W.-L.; Huang W.-F.; Wen Y.-W.; Tsai Y.-W.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:41Z |
Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: A nationwide population-based cohort study
|
HSIEN-YI CHIU; Huang H.-L.; Li C.-H.; Yin Y.-J.; Chen H.-A.; Hsu S.-T.; Lin S.-J.; Tsai T.-F.; Ho S.-Y. |
| 臺大學術典藏 |
2022-01-11T06:49:40Z |
The association between clinical response to ustekinumab and immunogenicity to ustekinumab and prior adalimumab
|
HSIEN-YI CHIU; Chu T.W.; Cheng Y.-P.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:40Z |
Correlation of IL36RN mutation with different clinical features of pustular psoriasis in Chinese patients
|
Wang T.-S.; HSIEN-YI CHIU; Hong J.-B.; Chan C.-C.; Lin S.-J.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:39Z |
Concomitant sleep disorders significantly increase the risk of cardiovascular disease in patients with psoriasis
|
HSIEN-YI CHIU; Hsieh C.-F.; Chiang Y.-T.; Tsai Y.-W.; Huang W.-F.; Li C.-Y.; Wang T.-S.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:38Z |
The risk of chronic pancreatitis in patients with psoriasis: A population-based cohort study
|
HSIEN-YI CHIU; Hsieh C.-F.; Chiang Y.-T.; Huang W.-F.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:38Z |
Risk of fractures in vitiligo patients treated with phototherapy-A retrospective population-based cohort study
|
Lo P.-C.; Li C.-Y.; Huang W.-F.; Tsai Y.-W.; Liu H.-N.; Chang Y.-T.; HSIEN-YI CHIU; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:38Z |
The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study
|
HSIEN-YI CHIU; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:37Z |
The impact of long-term secukinumab treatment on Epstein–Barr virus and cytomegalovirus loads in patients with psoriasis
|
HSIEN-YI CHIU; Chan C.-C.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:37Z |
Increased risk of aortic aneurysm (AA) in relation to the severity of psoriasis: A national population-based matched-cohort study
|
HSIEN-YI CHIU; Lo P.-C.; Huang W.-F.; Tsai Y.-W.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:36Z |
Secukinumab in psoriasis patients with prior ustekinumab treatment: Results of a single-center experience
|
Wang T.-S.; Chan C.-C.; HSIEN-YI CHIU; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:35Z |
An investigator-initiated, open-label, single-center, proof-of-concept-study of omalizumab in patients with poorly controlled acute urticaria
|
HSIEN-YI CHIU; Chan C.-C.; Chu C.-Y.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:35Z |
Increased risk of avascular necrosis in patients with psoriatic disease: A nationwide population-based matched cohort study
|
HSIEN-YI CHIU; Wang I.-T.; Huang W.-F.; Tsai Y.-W.; Shiu M.-N.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:34Z |
Risk of varicocele in patients with rheumatoid arthritis, ankylosing spondylitis, and psoriatic disease: a population-based case–control study
|
HSIEN-YI CHIU; Wang I.-T.; Huang W.-F.; Tsai Y.-W.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:34Z |
Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab
|
Hsiao C.-Y.; HSIEN-YI CHIU; Wang T.-S.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:33Z |
Safety profile of secukinumab in treatment of patients with psoriasis and concurrent hepatitis B or C: A multicentric prospective cohort study
|
HSIEN-YI CHIU; Hui R.C.-Y.; Huang Y.-H.; Huang R.-Y.; Chen K.-L.; Tsai Y.-C.; Lai P.-J.; Wang T.-S.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:32Z |
Risk of Psoriasis Following Terbinafine or Itraconazole Treatment for Onychomycosis: A Population-Based Case-Control Comparative Study
|
HSIEN-YI CHIU; Chang W.-L.; Tsai T.-F.; Tsai Y.-W.; Shiu M.-N. |
| 臺大學術典藏 |
2022-01-11T06:49:31Z |
Psoriasis in Taiwan: From epidemiology to new treatments
|
HSIEN-YI CHIU; Wang T.-S.; Chen P.-H.; Hsu S.-H.; Tsai Y.-C.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:30Z |
Psoriasis is associated with a greater risk for cardiovascular procedure and surgery in patients with hypertension: A nationwide cohort study
|
HSIEN-YI CHIU; Chang W.-L.; Shiu M.-N.; Huang W.-F.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:30Z |
Human leukocyte antigen and demographic characteristics in Chinese patients with active peripheral type psoriatic arthritis who had inadequate response to conventional disease-modifying antirheumatic drugs in a single dermatologic clinic
|
Sin C.-Z.; Wang T.-S.; HSIEN-YI CHIU; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:29Z |
Prevalence, clinical features and treatment pattern of patients with concurrent diagnoses of rheumatoid arthritis and psoriatic disease: results of a 14-year retrospective study in a tertiary referral center
|
Chen K.-L.; HSIEN-YI CHIU; Lin J.-H.; Ye J.-D.; Cho Y.-H.; Li K.-J.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:29Z |
Effectiveness and safety of secukinumab for psoriasis in real-world practice: analysis of subgroups stratified by prior biologic failure or reimbursement
|
Ger T.-Y.; Huang Y.-H.; Hui R.C.-Y.; Tsai T.-F.; HSIEN-YI CHIU |
| 臺大學術典藏 |
2022-01-11T06:49:28Z |
Clinical Features and Genetic Polymorphism in Chinese Patients with Erythrodermic Psoriasis in a Single Dermatologic Clinic
|
Lo Y.; HSIEN-YI CHIU; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:28Z |
The seroconversion rate of QuantiFERON-TB Gold In-Tube test in psoriatic patients receiving secukinumab and ixekizumab, the anti-interleukin-17A monoclonal antibodies
|
Wu C.-Y.; HSIEN-YI CHIU; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:28Z |
Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment
|
Yeh N.-L.; Hsu C.-Y.; Tsai T.-F.; HSIEN-YI CHIU |
| 臺大學術典藏 |
2022-01-11T06:49:27Z |
National trends in incidence, mortality, hospitalizations, and expenditures for pemphigus in Taiwan
|
HSIEN-YI CHIU; Chang C.J.; Lin Y.J.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:27Z |
Reactivation of Epstein-Barr virus and cytomegalovirus in patients with psoriasis after ustekinumab treatment
|
Hsieh C.-Y.; HSIEN-YI CHIU; Hua T.-C.; Tsai T.-F. |
| 臺大學術典藏 |
2022-01-11T06:49:25Z |
Recommendations for psoriatic arthritis management: A joint position paper of the Taiwan Rheumatology Association and the Taiwanese Association for Psoriasis and Skin Immunology
|
Tsai T.-F.; Hsieh T.-Y.; Chi C.-C.; Chou C.-T.; Hsieh L.-F.; Chen H.-H.; Hui R.C.-Y.; Lee C.-H.; Liu C.-H.; Liu H.-C.; Yeo K.-J.; Chen C.-H.; Chen H.-A.; Chen Y.-C.; Chen Y.-J.; HSIEN-YI CHIU; Ho J.-C.; Huang Y.-H.; Lai P.-J.; Lee W.-R.; Liao H.-T.; Lin S.-H.; Tseng J.-C.; Wang T.-S.; Wu N.-L.; Yang D.-H.; Tsai W.-C.; Wei J.C.-C.; Taiwan Rheumatology Association (TRA); the Taiwanese Association for Psoriasis; Skin Immunology (TAPSI) |
| 臺大學術典藏 |
2022-01-11T06:49:24Z |
Predictors of hepatitis B and C virus reactivation in patients with psoriasis treated with biologic agents: a 9-year multicenter cohort study
|
HSIEN-YI CHIU; Chiu Y.-M.; Chang Liao N.-F.; Chi C.-C.; Tsai T.-F.; Hsieh C.-Y.; Hsieh T.-Y.; Lai K.-L.; Chiu T.-M.; Wu N.-L.; Hui R.C.-Y.; Lee C.-N.; Wang T.-S.; Chen P.-H.; Yang C.-C.; Huang Y.-H. |
| 臺大學術典藏 |
2021-12-01T02:30:29Z |
Multiple Epstein-Barr virus-associated subcutaneous angioleiomyomas in a patient with acquired immunodeficiency syndrome
|
Chang J.Y.-F.; Wang C.-S.; CHIEN-CHING HUNG; Tsai T.-F.; Hsiao C.-H. |
| 臺大學術典藏 |
2021-11-18T02:47:37Z |
Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction
|
Tjiu J.-W.; Chen J.-S.; Shun C.-T.; Lin S.-J.; Liao Y.-H.; Chu C.-Y.; Tsai T.-F.; Chiu H.-C.; YANG-SHIA DAI; Inoue H.; Yang P.-C.; Kuo M.-L.; Jee S.-H. |
